GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


PHARMACOVIGILANCE REGULATORY PROCESSES


OBJECTIVES



To enable participants (specialists) to develop an understanding of the requirements of the Pharmaceutical Industry’s operational aspects of pharmacovigilance as it relates to the preparation and assessment of documents legally required by regulatory bodies.

Focus will be on the adverse event reporting process within Industry, placed within the context of regulatory requirements and best practice.

Legislation, regulation, processes, procedures, documentation

 

MODULE PARTS



  1. Case reporting
  2. Periodic reporting
  3. Product Labelling and Risk Management Plans
  4. Contractual arrangements.

 

TRAINER TEAM



Coordinator: Dr Sherael Webley (from University of Hertfordshire)

Expert(s): Dr Marika Vousden, Bharat Amlani (from University of Hertfordshire), John Talbot (from AstraZeneca AB), Dr Justina Orleans-Lindsay (from Acadustri Ltd), Robert Grice (from GlaxoSmithKline Research and Development Ltd), Helen Robinson (from Pfizer), Dr David Lewis (from Novartis Pharma AG), Philippa Guy (from Saffron Health), Sarah Hall (Independent), Dr Susan Duke (from F. Hoffmann-La Roche Ltd).

Intermediate level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 or PhD programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

APPLY NOW

Applications open until December 08th, 2017

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners